Select Bibliography

Filter by any of these (after searching):

Dalton, Robert J

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2 items

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

Barton, Debra L , Wender, Donald B , Sloan, Jeff A , Dalton, Robert J ... - - J Natl Cancer Inst - 2007

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N02C3

Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group

Witzig, Thomas E. , Geyer, Susan M. , Kurtin, Paul J. ... - - Leuk Lymphoma - 2008

Manuscript - Primary - Primary - Lymphoma - N9981